Popular Articles

Anti Nausea Drug Deemed Safe For Fetuses: Ben-Gurion U.
Metoclopramide, a drug approved in the U.S. for nausea, vomiting and heartburn poses no significant risks for the fetus according to a large cohort study published in the June 11 issue of the prestigious New England Journal of Medicine, "The Safety of Metoclopramide Use in the First Trimester of Pregnancy" (N Engl J Med 2009;360:24 June 11, 2009).

Repair Of Heart Defect Discovered Incidentally During Surgery May Not Have Clear Benefit
Patients who have a heart defect known as patent foramen ovale incidentally discovered and repaired during surgery for a different condition may have an increased odds of postoperative stroke, along with no clear benefit on short-term outcomes or long-term survival, according to a study in the July 15 issue of JAMA.
News of the day
Genomic Health's Oncotype DX(R) Colon Cancer Test Predicts Individualized Recurrence Risk For Stage II Colon Cancer Patients
Genomic Health, Inc. (Nasdaq: GHDX) announced positive results from the landmark QUASAR validation study, which demonstrated that the Oncotype DX(R) colon cancer test can independently predict individual recurrence risk in stage II colon cancer patients following surgery. Importantly, the Oncotype DX colon cancer Recurrence Score(R) provided additional independent clinical value beyond standard measures. The study showed that the colon cancer Recurrence Score maintained significance (p=0.008), independent of mismatch repair (MMR), also known as MSI (Microsatellite Instability), T-stage, nodes examined, grade and lymphovascular invasion.
Cardiovascular

Turner Syndrome Society Of The United States Announces Ambitious Goal To Crush Ignorance Of Turner Syndrome (TS)

The Turner Syndrome Society of the United States (TSSUS) recently concluded its 22nd Annual Conference in Portland, Oregon. The conference drew more than 350 individuals, families, researchers and health care professionals to network and learn about the latest research breakthroughs benefiting women and girls with TS. TSSUS continues to make great strides toward helping identify and assist those with TS. With that in mind the TSSUS board of directors met and unanimously agreed on setting an ambitious goal to Crush Ignorance of Turner Syndrome over the next decade. The TSSUS board also laid the groundwork for new fundraising, finance and public relations initiatives designed to professionalize the association and increase awareness of TS. One example: a board priority to "ensure that all short girls are evaluated for Turner syndrome will be advanced with a TSSUS produced brochure designed to promote this objective which will be mailed to all pediatricians in the US." "TSSUS continues to improve TS identification, outreach, and public relations efforts--now more important than ever, given economic conditions, competition for scarce res, and the current health care reform debate," said Cindy Dunnam, TSSUS executive director. "In spite of the climate of economic uncertainty the meeting was an economic success. More important was the boards" agreement on a clear direction and purpose for the Society over the next decade," continued Dunnam. "This speaks to the value of what TSSUS offers to those who are interested in helping those with Turner syndrome." The TSSUS 2010 meeting will be held in Indianapolis, Indiana at the Hyatt Regency, July 2nd-July 4th. See TSSUS" website for more information: http://www.turnersyndrome.org Turner Syndrome (TS) is a condition that affects only females - more than 75,000 in the United States alone. Main visible feature: short stature, usually below the 5th percentile of height in the female population. Early diagnosis and intervention is critical. If you already know about TS, tell a friend, family member, business associate or health care professional and help us Crush Ignorance of Turner Syndrome! We can"t do it without you. Turner Syndrome Society of the United States


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):